Form 4 for CNSP CNS Pharmaceuticals, Inc.
Accepted 2023-08-23 00:00:00 ET · period of report 2023-08-22 · accession 0001683168-23-006001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-23 | 2023-08-22 | CNSP | Downs Christopher | CFO | P - Purchase | $1.27 | +27.0K | 36.8K | +276% | +$34.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-22 | P | A | 27,000 | $1.27 | 36,772 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $1.2196 to $1.2999. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |